Catalyst Biosciences, Wyeth deal

Pfizer Inc. (NYSE:PFE, New York, N.Y.) will exercise its right to terminate a 2009 deal granting Wyeth, now part of Pfizer, an exclusive, worldwide license to develop and commercialize the biotech’s ...